The acute phase response stimulates the expression of angiopoietin like protein 4.

[1]  P. Libby.  Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Robert V Farese,et al.  Angiopoietin-like 4 (ANGPTL4, Fasting-induced Adipose Factor) Is a Direct Glucocorticoid Receptor Target and Participates in Glucocorticoid-regulated Triglyceride Metabolism* , 2009, The Journal of Biological Chemistry.

[3]  A. Xu,et al.  A Highly Conserved Motif within the NH2-terminal Coiled-coil Domain of Angiopoietin-like Protein 4 Confers Its Inhibitory Effects on Lipoprotein Lipase by Disrupting the Enzyme Dimerization* , 2009, Journal of Biological Chemistry.

[4]  J. Olefsky,et al.  Insulin sensitivity: modulation by nutrients and inflammation. , 2008, The Journal of clinical investigation.

[5]  S. Corvera,et al.  Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. , 2008, American journal of physiology. Endocrinology and metabolism.

[6]  M. Morishima,et al.  Bezafibrate improves bacterial lipopolysaccharide-induced dyslipidemia and anorexia in rats. , 2007, Metabolism: clinical and experimental.

[7]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[8]  T. Olivecrona,et al.  Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue , 2006, Proceedings of the National Academy of Sciences.

[9]  K. Feingold,et al.  Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response Published, JLR Papers in Press, July 17, 2006. , 2006, Journal of Lipid Research.

[10]  Cai Li.  Genetics and regulation of angiopoietin-like proteins 3 and 4 , 2006, Current opinion in lipidology.

[11]  J. Cha,et al.  Differential regulation and properties of angiopoietin-like proteins 3 and 4 Published, JLR Papers in Press, May 1, 2005. DOI 10.1194/jlr.M500005-JLR200 , 2005, Journal of Lipid Research.

[12]  Kenneth R Feingold,et al.  Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. , 2004, Journal of lipid research.

[13]  J. Pickup.  Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. , 2004, Diabetes care.

[14]  K. Feingold,et al.  Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. , 2004, American journal of physiology. Endocrinology and metabolism.

[15]  Kenichi Yoshida,et al.  Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase Published, JLR Papers in Press, September 16, 2002. DOI 10.1194/jlr.C200010-JLR200 , 2002, Journal of Lipid Research.

[16]  P. Chambon,et al.  Characterization of the Fasting-induced Adipose Factor FIAF, a Novel Peroxisome Proliferator-activated Receptor Target Gene* , 2000, The Journal of Biological Chemistry.

[17]  K. Feingold,et al.  The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver* , 2000, The Journal of Biological Chemistry.

[18]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[19]  K. Feingold,et al.  Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. , 1994, Cytokine.

[20]  J. Gauldie,et al.  The acute phase response. , 1994, Immunology today.

[21]  S. Fried,et al.  Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity. , 1989, Journal of lipid research.

[22]  K. Feingold,et al.  Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. , 1989, Journal of lipid research.

[23]  T. Chajek-Shaul,et al.  Lipoprotein lipase in heart cell cultures is suppressed by bacterial lipopolysaccharide: an effect mediated by production of tumor necrosis factor. , 1988, Biochimica et biophysica acta.

[24]  J. Tavernier,et al.  Tissue-specific regulation of guinea pig lipoprotein lipase; effects of nutritional state and of tumor necrosis factor on mRNA levels in adipose tissue, heart and liver. , 1988, Gene.

[25]  S. Enerbäck,et al.  Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells by tumour necrosis factor. , 1988, The Biochemical journal.

[26]  G. Bagby,et al.  Triacylglycerol kinetics in endotoxic rats with suppressed lipoprotein lipase activity. , 1987, The American journal of physiology.

[27]  J. Tavernier,et al.  Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. , 1987, The Journal of biological chemistry.

[28]  M. Kawakami,et al.  Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. , 1987, Journal of biochemistry.

[29]  B. Aggarwal,et al.  Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B. Beutler,et al.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells , 1985, The Journal of experimental medicine.

[31]  A. Cerami,et al.  Studies of endotoxin-induced decrease in lipoprotein lipase activity , 1981, The Journal of experimental medicine.

[32]  Richard Graham Knowles,et al.  Bacterial endotoxin effects on carbohydrate utilization and transport , 2009 .

[33]  M. Tabata,et al.  The role of angiopoietin-like proteins in angiogenesis and metabolism. , 2008, Trends in cardiovascular medicine.

[34]  S. Kersten.  Regulation of lipid metabolism via angiopoietin-like proteins. , 2005, Biochemical Society transactions.

[35]  L. Chan,et al.  Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level. , 1993, Journal of lipid research.